title: Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003).
abstract: The aim of this study was to determine the distribution of the antimicrobial resistance phenotypes (R types), the phage types and XbaI-pulsed-field gel electrophoresis (PFGE) types, the genes coding for resistance to beta-lactams and to quinolones, and the class 1 integrons among a representative sample of Salmonella enterica serotype Typhimurium isolates collected from humans in 2002 through the French National Reference Center for Salmonella (NRC-Salm) network. The trends in the evolution of antimicrobial resistance of serotype Typhimurium were reviewed by using NRC-Salm data from 1993, 1997, 2000, and 2003. In 2002, 3,998 isolates of serotype Typhimurium were registered at the NRC-Salm among 11,775 serotyped S. enterica isolates (34%). The most common multiple antibiotic resistance pattern was resistance to amoxicillin, chloramphenicol, streptomycin and spectinomycin, sulfonamides, and tetracycline (ACSSpSuTe R type), with 156 isolates (48.8%). One isolate resistant to extended-spectrum cephalosporins due to the production of TEM-52 extended-spectrum beta-lactamase was detected (0.3%), and one multidrug-resistant isolate was highly resistant to ciprofloxacin (MIC > 32 mg/liter). We found that 57.2% of the isolates tested belonged to the DT104 clone. The main resistance pattern of DT104 isolates was R type ACSSpSuTe (83.2%). However, evolutionary changes have occurred within DT104, involving both loss (variants of Salmonella genomic island 1) and acquisition of genes for drug resistance to trimethoprim or to quinolones. PFGE profile X1 was the most prevalent (74.5%) among DT104 isolates, indicating the need to use a more discriminatory subtyping method for such isolates. Global data from the NRC-Salm suggested that DT104 was the main cause of multidrug resistance in serotype Typhimurium from humans from at least 1997 to 2003, with a roughly stable prevalence during this period.
authors.affiliation: Centre National de Référence des Salmonella, Unité de Biodiversité des Bactéries Pathogènes Emergentes, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris cedex 15, France. fxweill@pasteur.fr
authors.forename: François-Xavier
authors.initials: FX
authors.lastname: Weill
authors.forename: Françoise
authors.initials: F
authors.lastname: Guesnier
authors.forename: Véronique
authors.initials: V
authors.lastname: Guibert
authors.forename: Mohammed
authors.initials: M
authors.lastname: Timinouni
authors.forename: Marie
authors.initials: M
authors.lastname: Demartin
authors.forename: Lucette
authors.initials: L
authors.lastname: Polomack
authors.forename: Patrick A D
authors.initials: PA
authors.lastname: Grimont
mesh_terms: D001434:Bacteriophage Typing; D001483:Base Sequence; D004269:DNA, Bacterial / Q000235:genetics / Q000302:isolation & purification; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D016521:Electrophoresis, Gel, Pulsed-Field; D019143:Evolution, Molecular; D005602:France; D005798:Genes, Bacterial; D006801:Humans; D032023:Integrons; D008826:Microbial Sensitivity Tests; D010641:Phenotype; D012478:Salmonella Food Poisoning / Q000382:microbiology; D012483:Salmonella Phages / Q000145:classification / Q000302:isolation & purification; D012486:Salmonella typhimurium / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification / Q000821:virology; D013997:Time Factors
chemical_list: D004269:DNA, Bacterial